Events

Exploring emerging targets such as USP1 and WRN – these combined efforts are making DDR inhibitor drug development an increasingly dynamic and transformative area.

Showcase the latest delivery technologies, data from clinically successful extra-hepatic targeting, cutting-edge AI tools to assist payload design, and breakthrough chemical modifications

Features all-new insights on building a quality culture, maintaining compliance throughout change management, and securing buy-in and support from executive leadership for your risk planning strategy

Designed to provide attendees with up-to-date, practical information and best practices that can be applied immediately into daily clinical practice

Offers a timely opportunity to explore the latest breakthroughs and emerging trends driving the future of agricultural biotechnology.

The Pharma Market Research Conference is the key to uncovering knowledge and developing new business relationships.

It showcase the latest innovations in AI integration, novel reimbursement avenues and alternative regulatory pathways to achieve commercial viability.

Liquid biopsy testing has continued to revolutionize diagnostics and personalized medicine; from the integration of AI and automation to elevate liquid biopsy capabilities, to the approval of MRD as an endpoint in Multiple Myeloma.

A dedicated forum to advancing novel radiopharmaceutical drug discovery. Delve deep into target mining, screening, discovery and selection from ROR1, uPAR, B7-H3, NECTIN-4, CAIX and more.

This year’s all-new agenda offers unprecedented detail on optimizing digital innovation, working with regulatory and legal review partners, and exploring how to establish a culture on innovation.